CS-196failure
Government of Mexico: the Secretaría de Hacienda (Oficialía Mayor), the Instituto de Salud para el Bienestar (INSABI) and the Health Secretariat, buying through the UN Office for Project Services (UNOPS)
Centralised federal procurement and distribution of public-sector medicines: consolidated purchasing moved from IMSS to Hacienda (2019), then to INSABI with UNOPS as international buyer (2020-2022), ending with UNOPS's early exit and INSABI's extinction (2023)
- Region
- Latin America
- Country
- Mexico
- Industry
- Public Sector and Government (Other (cross-industry))
- Functions
- Procurement & Strategic Sourcing, Supply Chain & Logistics, Operations & Service Delivery, Risk, Compliance & Internal Audit, Strategy, Corporate Development & Transformation Office
- Topics
- Supply chain disruption has made the network fragile; Inventory is simultaneously excessive and unavailable; Service delivery is too slow, unreliable or expensive; Supplier inflation and procurement leakage are unsustainable; Cross-functional processes are slow and broken
- Starting situation
- New initiative
- Period
- 2019–2023
- Last verified
- 5 November 2026
Executive summary
In 2019 Mexico's federal government took the buying of medicines for the public health system away from the social-security institute IMSS, which had run consolidated tenders for about a decade, and centralised it first in the Finance Ministry and then, from 2020, in a new body, INSABI, using the UN Office for Project Services as its international buyer [C01, C05, C06, C21]. The stated aims were better prices, an end to what the president called a corrupt purchasing system, and high-quality medicines at low cost [C01, C06, C11].
The new process missed the calendar the old one kept. In 2019 62% of the second-half tender was declared deserted; in 2021 UNOPS awarded about half of the keys it was asked to buy, and the government bought the rest in emergency direct awards [C03, C10, C18]. The federal auditor found that only part of 2021 demand was met and that INSABI lacked basic controls [C12, C13, C14, C15]. Unfilled prescriptions rose from 3.7m in 2018 to 27.4m in 2021 on a civil-society count [C23].
The model was then dismantled: INSABI ended the UNOPS agreement about two years early in October 2022, and INSABI itself was extinguished by law in May 2023, with its functions passed to IMSS-Bienestar [C19, C20, C24, C25]. The lesson for any organisation that buys and distributes critical supplies: replacing a working supply process with an untested one, before the new buyer, the distribution and the controls exist, transfers the risk to the people who depend on the supplies.
Outcome: failure
The initiative was abandoned, exited or written down, or an official finding called it a failure.
Basis of the outcome
The objective stated at the start was to buy medicines for the public health institutions through a centralised, consolidated process at better prices, and later, through UNOPS, to obtain high-quality medicines at low prices (S14, S07). Three documented facts support the failure class. (1) The arrangement was abandoned: INSABI ended the UNOPS agreement about two years early, in October 2022 (S04, S06), and the law creating INSABI was amended in May 2023 to extinguish it and move its functions to IMSS-Bienestar and the Health Secretariat (S08, S17). (2) The federal auditor (ASF) found internal-control weaknesses in INSABI's 2021 consolidated purchase and issued five recommendations and four referrals for administrative sanction (S01); press reports of the same audit say that only 58.4% of the year's demand was awarded (S02) and that the auditor concluded that the medicine needs were not fully met (S03). (3) Unfilled prescriptions in the public system rose from 3.7m in 2018 to 27.4m in 2021 on Cero Desabasto's count (S10). Against this, the government and UNOPS reported savings and a wider supplier base (S12, S16), and fill rates recovered in 2023 after procurement and supply had moved back towards IMSS (S10).
Key figures
| Phase | Figure | Value | When | Verification |
|---|---|---|---|---|
| Before | Prescriptions not fully filled | 3.7m | 2018 | press_reported |
| During | Second-half tender declared deserted | 62% | Jun 2019 | press_reported |
| During | UNOPS keys awarded in main 2021 round | 1,050 of 3,485 | 2021 | official_finding |
| During | Payments to the UNOPS project from FONSABI | MXN 23,888.8m | 2021 | official_finding |
| During | Share of 2021 demand awarded | 58.4% | 2021 | press_reported |
| During | Prescriptions not fully filled | 27.4m | 2021 | press_reported |
| After | ASF recommendations and sanction referrals | 5 and 4 | Feb 2023 | official_finding |
| After | Megafarmacia deliveries in first months | 648 of 7,593 (8.5%) | Apr 2024 | press_reported |
- press_reported
- A journalist's own reporting.
- official_finding
- A finding of an inquiry, court or regulator.
Practices this case bears on
- SupportsGate every go-live on measured readiness, not on the calendar BP-001
- SupportsRoll out operational and system change in waves, each proven before the next BP-006
- SupportsTie every benefit to the financial statements, bank it before counting it, and keep tracking after the programme ends BP-010
- SupportsLimit how many things change at once, for the business and for the customer BP-012
- SupportsBudget the whole-life cost of a core programme, treat budget rises as new decisions, and retire legacy on a dated plan BP-013
- SupportsOutsource only what does not differentiate, and keep the capability to specify, integrate and replace partners BP-017
- SupportsTreat vendor attestations, awards and executive testimony as claims to test, not as assurance BP-019
- SupportsMake bad news safe and fast to reach the top, and act on it BP-022
- SupportsInvestigate failures independently at full scale, let outsiders validate the fix, and turn the findings into permanent checks BP-026
- SupportsAnnounce only targets the evidence supports, build synergy estimates from shared data, and re-base them openly BP-033
- SupportsDefine and freeze each programme metric before reporting it, and keep it comparable BP-034
- SupportsSeparate the programme's own effect from tailwinds, shocks and one-off gains before claiming credit BP-035
- SupportsJudge an integration by customer retention and revenue health, not by synergy capture BP-036
- SupportsWrite exit and pause criteria at approval, and treat impairments as triggers to re-test the strategy BP-042
- SupportsMap critical dependencies several tiers deep, buffer what cannot be re-sourced, and decide who pays for resilience BP-064
- SupportsBuild the enabling architecture and infrastructure before the applications that depend on it BP-071
Sources
- S01 Auditoría de Cumplimiento 2021-1-19GYN-19-0132-2022: Adquisición Consolidada de Medicamentos y Material de Curación (Instituto de Salud para el Bienestar) · Auditoría Superior de la Federación, Auditoría Superior de la Federación, 2023-02 · accessed 2026-11-05
- S02 Fracasa Compra Consolidada de Medicamentos; Solo Logró 58% en 2021: ASF · not stated (con información de N+), N+, 2023-02-21 · accessed 2026-11-05
- S03 ASF: compras de medicinas del Insabi, con deficiencias e irregularidades · Dulce Soto, Expansión Política, 2023-02-21 · accessed 2026-11-05
- S04 Insabi cierra convenios con UNOPS para la compra de medicamentos · Ariadna Ortega, Expansión Política, 2022-10-05 · accessed 2026-11-05
- S05 UNOPS and Medicine Acquisition in Mexico: A Failed Project · Rafael Gual, Mexico Business News, 2023-01-12 · accessed 2026-11-05
- S06 El INSABI anuncia la compra de medicamentos por parte del gobierno federal ante la terminación de la colaboración con la UNOPS · IMCO Staff, Instituto Mexicano para la Competitividad (IMCO), 2022-10-10 · accessed 2026-11-05
- S07 Despite new system to buy and distribute medications, shortages continue · MND Staff, Mexico News Daily, 2021-03-30 · accessed 2026-11-05
- S08 La desaparición del Insabi ya es oficial: comenzará su proceso para integrarlo al IMSS-Bienestar · Lizeth Morales, Infobae México, 2023-05-29 · accessed 2026-11-05
- S09 Recetas sin surtir se triplican con AMLO, dice Cero Desabasto · Ariadna Ortega, Expansión Política, 2022-03-07 · accessed 2026-11-05
- S10 Un sexenio con desabasto de medicamentos: 82 millones de recetas incompletas · Dulce Soto, Expansión Política, 2024-06-01 · accessed 2026-11-05
- S11 Gobierno declara desierta 62% de la compra consolidada en sector salud · Pool CEO, El CEO, 2019-06-29 · accessed 2026-11-05
- S12 UNOPS no logró cumplir la meta y Salud salió a comprar faltantes en 37 días · Ariadna Ortega, Expansión Política, 2021-07-20 · accessed 2026-11-05
- S13 UNOPS logra ahorro de 117 mdd en primeras compras de medicamentos · Jorge Chaparro, La Razón de México, 2021-03-23 · accessed 2026-11-05
- S14 Hacienda culpa al gobierno de Peña de la falta de medicinas · Cristóbal Martínez Riojas, Expansión, 2019-05-24 · accessed 2026-11-05
- S15 Megafarmacia del Bienestar ha entregado sólo el 8.5% de medicamentos solicitados · Redacción Animal Político, Animal Político, 2024-05-20 · accessed 2026-11-05
- S16 Pese a fallas, la ONU premia el modelo de compras entre México y la UNOPS · Dulce Soto, Expansión Política, 2022-10-14 · accessed 2026-11-05
- S17 SSa Federal publica en DOF decreto que desaparece al INSABI; lo absorbe el IMSS-Bienestar · Carlos Álvarez Acevedo, Semanario ZETA, 2023-05-30 · accessed 2026-11-05
Researched and fact-checked knowledgebase · Knowledgebase built 5 November 2026 · Last verified 5 November 2026
Practices, their evidence grades and case summaries are public. Full case studies are available in AXIOM to subscribers and AXIOM Discover participants.

